Causes of Elevated Troponin
Elevated troponin levels can result from numerous cardiac and non-cardiac conditions, with the most frequent causes being tachyarrhythmias, heart failure, hypertensive emergencies, critical illness, myocarditis, Takotsubo syndrome, and valvular heart disease. 1
Primary Cardiac Causes
Acute Coronary Syndromes
- Type 1 myocardial infarction (thrombotic occlusion)
Other Cardiac Causes
- Heart failure (acute and chronic) 1
- Tachyarrhythmias and bradyarrhythmias 1
- Myocarditis 1
- Takotsubo syndrome (stress cardiomyopathy) 1
- Valvular heart disease (especially aortic stenosis) 1
- Hypertensive emergencies/crisis 1
- Cardiac procedures:
- Cardiac contusion
- Ablation
- Pacing
- Cardioversion
- Endomyocardial biopsy
- CABG and PCI 1
- Hypertrophic cardiomyopathy 1
Non-Cardiac Causes
Vascular Conditions
Systemic Conditions
- Critical illness (shock/sepsis/burns) 1, 2
- Renal dysfunction and associated cardiac disease 1
- Acute neurological events:
- Stroke
- Subarachnoid hemorrhage 1
- Endocrine disorders:
- Hypothyroidism
- Hyperthyroidism 1
- Infiltrative diseases:
- Amyloidosis
- Haemochromatosis
- Sarcoidosis
- Scleroderma 1
- Drug toxicity or poisoning:
- Doxorubicin (Adriamycin)
- 5-fluorouracil
- Herceptin (trastuzumab)
- Snake venoms 1
- Extreme endurance effort 1
- Rhabdomyolysis 1
- Burns affecting >30% of body surface area 1
Interpretation of Troponin Elevation
Clinical Context is Critical
- Troponin elevation indicates myocardial injury but alone cannot establish MI diagnosis 3
- Elevations up to 3-fold the upper reference limit have limited (50-60%) PPV for AMI 1
- Rising and/or falling pattern helps differentiate acute from chronic damage 1
Prognostic Significance
- Elevated troponin is associated with increased mortality in many conditions, even non-ACS 3, 4
- In ICU patients with MI (defined by troponin elevation plus ischemic changes), mortality is significantly higher than those without MI 3
Common Pitfalls in Troponin Interpretation
Failing to consider non-ACS causes: Elevated troponin is not synonymous with coronary thrombosis 5
Inappropriate treatment: Patients with non-thrombotic troponin elevation should not receive antithrombotic and antiplatelet agents without evidence of ACS 5
Dismissing elevations in elderly or renal patients: These elevations often indicate underlying cardiac pathology and confer poor prognosis 2
Relying on single measurements: Serial testing is essential, looking for significant rise and/or fall pattern 2
Missing MI in critically ill patients: In the ICU setting, 47% of patients may have elevated troponin but only 26% meet criteria for MI 3
Diagnostic Approach
Serial measurements: Obtain troponin at presentation and 1-2 hours later (with high-sensitivity assays) or 6-12 hours later (with conventional assays) 2
Look for dynamic changes: A significant rise and/or fall pattern suggests acute myocardial injury 1, 2
Correlate with clinical presentation: Assess for ischemic symptoms, ECG changes, or new wall motion abnormalities 3
Consider the magnitude of elevation: Higher levels increase likelihood of ACS, but any elevation has prognostic significance 1, 2
Evaluate for non-ACS causes: Systematically consider other cardiac and non-cardiac conditions that may explain troponin elevation 6
By understanding the diverse causes of troponin elevation and applying a systematic approach to interpretation, clinicians can avoid misdiagnosis and ensure appropriate management of patients with elevated troponin levels.